🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities! 🎄🌟 🎉
🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities! 🎄🌟 🎉

Cynosure and Lutronic Announce Merger to Create a Leading Global Medical Aesthetics Technology Company

25th January, 2024 | By Vrushti Kothari 

Cynosure and Lutronic Join Forces to Form a Pinnacle Global Medical Aesthetics Technology Powerhouse

Cynosure and Hahn & Company, which has recently acquired Lutronic, announced that they have entered into a definitive merger agreement for a strategic combination of Cynosure and Lutronic. Both Cynosure and Lutronic are global providers of energy-based medical aesthetic treatment systems and related technologies. The transaction is expected to close in the first quarter of 2024, subject to customary closing conditions.

This strategic combination creates a global leader in medical aesthetic systems with a diversified, innovative product portfolio and a commercial presence in over 130 countries. The combined company offers customers and patients a broader product and consumables suite, a depth of related clinical training and services, expanded research and development capabilities, an enhanced geographic footprint to serve more customers around the world and a reinforced supply chain to ensure seamless continuity of products and services.

"The strategic combination will create a combined company with the resources, product portfolio and expertise that will benefit our customers, partners and employees," said Nadav Tomer, CEO of Cynosure. "We are thrilled that Cynosure is partnering with Lutronic as we believe this will create a distinct opportunity to combine two strong global players in energy-based medical device technology for aesthetics."

"Partnering with Cynosure is a meaningful and transformational next step in diversifying our portfolio and scaling our company," said Haelyung Hwang, Founder and CEO of Lutronic. "This strategic combination furthers Lutronic's mission to drive innovation and provide superior products and customer service to aesthetics providers around the world. Cynosure's innovative medical device technology, commercial infrastructure and best-in-class brand-building capabilities will broaden our product line and customer base globally."

Jefferies LLC served as exclusive financial advisor to Cynosure. Weil, Gotshal & Manges LLP and Debevoise & Plimpton LLP served as legal advisors to Cynosure. PJT Partners LP served as exclusive financial advisor to Lutronic and Cleary Gottlieb Steen & Hamilton LLP and Kim & Chang served as legal advisors to Lutronic and Hahn & Company.

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer